Investigating the link between serum concentrations of brain-derived neurotrophic factor and behavioral measures in anxious alcohol-dependent individuals.


Journal

Alcohol (Fayetteville, N.Y.)
ISSN: 1873-6823
Titre abrégé: Alcohol
Pays: United States
ID NLM: 8502311

Informations de publication

Date de publication:
12 2020
Historique:
received: 17 02 2020
revised: 24 07 2020
accepted: 24 07 2020
pubmed: 18 8 2020
medline: 16 9 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

Brain-derived neurotrophic factor (BDNF) plays a role in different neurophysiological processes, including those involved in alcohol- and anxiety-related behaviors. Preclinical and clinical studies indicate that chronic excessive alcohol use leads to a downregulation of BDNF production in the periphery and in the brain. In addition, a decrease in BDNF concentrations in the blood has been reported to be associated with increased anxiety levels. Non-treatment-seeking alcohol-dependent individuals with high trait anxiety were studied to assess whether serum BDNF concentrations may be linked to self-reported levels of alcohol drinking, anxiety, and other behavioral measures. Participants had a current diagnosis of alcohol dependence, high trait anxiety score, and were not seeking treatment for alcohol dependence or anxiety. A fasting blood sample was collected from each participant and serum BDNF was measured using an enzyme-linked immunosorbent assay (ELISA). Behavioral data were collected on the same day, including measures of alcohol drinking, craving, dependence severity, and anxiety. Bivariate correlations were run between BDNF levels and behavioral measures. Serum BDNF concentrations were negatively correlated with average drinks per drinking days (r = -0.41, p = 0.02) and positively correlated with obsessive-compulsive drinking scale (r = 0.48, p = 0.007) and state-trait anxiety inventory (r = 0.52, p = 0.003) scores. These findings shed light on the possible role of the BDNF system in the neurobiology of alcohol- and anxiety-related behaviors.

Identifiants

pubmed: 32798692
pii: S0741-8329(20)30253-6
doi: 10.1016/j.alcohol.2020.07.009
pmc: PMC7722014
mid: NIHMS1621787
pii:
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
Ethanol 3K9958V90M

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-83

Subventions

Organisme : NIAAA NIH HHS
ID : R37 AA016848
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AA000218
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest There are no conflicts of interest.

Références

Alcohol Clin Exp Res. 2009 Apr;33(4):693-702
pubmed: 19170664
Biol Psychiatry. 2009 Jul 1;66(1):84-90
pubmed: 19358977
Vitam Horm. 2017;104:475-496
pubmed: 28215305
Alcohol. 2016 Aug;54:67-72
pubmed: 27514572
Alcohol Res. 2012;34(4):414-31
pubmed: 23584108
World J Psychiatry. 2016 Mar 22;6(1):84-101
pubmed: 27014600
Biomed Res Int. 2019 Jun 10;2019:3426092
pubmed: 31281833
Biol Psychiatry. 2007 Jan 15;61(2):187-97
pubmed: 16697351
Rev Neurosci. 2017 Jul 26;28(5):499-508
pubmed: 28306543
Trends Neurosci. 2014 Apr;37(4):219-27
pubmed: 24636458
Neuroscience. 2017 Apr 21;348:324-334
pubmed: 28257889
J Psychiatr Res. 2014 Dec;59:1-7
pubmed: 25258340
Curr Opin Neurobiol. 2013 Aug;23(4):649-54
pubmed: 23764204
Sci Rep. 2015 Dec 10;5:17989
pubmed: 26656852
Nat Rev Neurosci. 2016 Sep;17(9):576-91
pubmed: 27444358
J Neurosci. 2012 May 16;32(20):7074-81
pubmed: 22593075
Neuropsychiatr Dis Treat. 2011;7:357-64
pubmed: 21792305
J Neurochem. 2003 Jun;85(5):1139-47
pubmed: 12753073
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2475-84
pubmed: 22826346
Addict Biol. 2020 Mar 5;:e12890
pubmed: 32135570
Psychol Health Med. 2019 Apr;24(4):505-511
pubmed: 30269521
Psychiatry Res. 2011 Apr 30;186(2-3):427-30
pubmed: 20826006
Neuropsychobiology. 2013;67(1):6-13
pubmed: 23221871
Arch Med Sci. 2015 Dec 10;11(6):1164-78
pubmed: 26788077
Psychoneuroendocrinology. 2011 Nov;36(10):1562-9
pubmed: 21596481
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72
pubmed: 22588767
J Biol Rhythms. 2017 Feb;32(1):75-82
pubmed: 28326910
Neurobiol Dis. 2017 Jan;97(Pt B):119-126
pubmed: 27425886
Brain Res. 2015 Dec 2;1628(Pt A):60-7
pubmed: 25801118
Psychopharmacology (Berl). 2019 Dec;236(12):3525-3539
pubmed: 31280332
Psychoneuroendocrinology. 2011 Feb;36(2):228-39
pubmed: 20702043
Sci Rep. 2019 Mar 8;9(1):3991
pubmed: 30850750
Biol Psychiatry. 2016 Mar 15;79(6):463-73
pubmed: 26204799
Front Psychiatry. 2017 Sep 22;8:173
pubmed: 29018367
Transl Psychiatry. 2019 Apr 9;9(1):131
pubmed: 30967530
Transl Psychiatry. 2018 Mar 9;7(11):2
pubmed: 29520063
Compr Psychiatry. 1998 Jul-Aug;39(4):176-84
pubmed: 9675501
Handb Clin Neurol. 2014;125:133-56
pubmed: 25307573
Front Integr Neurosci. 2013 Jul 29;7:55
pubmed: 23908608
Psychopharmacology (Berl). 2016 Sep;233(17):3149-60
pubmed: 27370019
Commun Integr Biol. 2009;2(1):14-6
pubmed: 19704856
Am J Psychiatry. 2017 Dec 1;174(12):1203-1213
pubmed: 29084453
J Mol Cell Cardiol. 2017 Sep;110:54-60
pubmed: 28736262
Mol Psychiatry. 2015 Oct;20(10):1219-31
pubmed: 25330738
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15570-5
pubmed: 18832146
Br J Addict. 1989 Nov;84(11):1353-7
pubmed: 2597811
Science. 2006 Oct 6;314(5796):140-3
pubmed: 17023662
Biol Psychiatry. 2012 Sep 15;72(6):499-504
pubmed: 22552045
Nature. 1994 Mar 10;368(6467):147-50
pubmed: 8139657
Medicine (Baltimore). 2019 Mar;98(11):e14838
pubmed: 30882674
Neurosci Lett. 2011 Nov 21;505(3):273-8
pubmed: 22044872
J Neurosci Res. 2019 Mar;97(3):300-312
pubmed: 30402941
J Neurosci. 2014 Mar 26;34(13):4581-8
pubmed: 24672003
J Neurosci. 2009 Oct 28;29(43):13494-502
pubmed: 19864562
Front Behav Neurosci. 2019 Apr 11;13:70
pubmed: 31139059
Drug Alcohol Depend. 2018 Dec 1;193:91-103
pubmed: 30347311
Addict Biol. 2019 Sep;24(5):1019-1033
pubmed: 30277635
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1060-4
pubmed: 20553781
Neurobiol Stress. 2019 Jul 26;11:100186
pubmed: 31440532
Pharmacol Ther. 2011 Feb;129(2):149-71
pubmed: 20951730
J Cell Mol Med. 2018 Nov;22(11):5265-5277
pubmed: 30133147
Psychiatry Res. 2019 Aug;278:97-115
pubmed: 31174033
J Mol Cell Cardiol. 2008 Feb;44(2):380-7
pubmed: 18037433
CNS Drugs. 2014 Apr;28(4):343-60
pubmed: 24573997
Discov Med. 2018 Oct;26(143):127-136
pubmed: 30586536
FASEB J. 2008 Jul;22(7):2393-404
pubmed: 18310464
Science. 2010 Feb 12;327(5967):863-6
pubmed: 20075215
Psychiatry Res. 2010 Aug 30;179(1):86-90
pubmed: 20478625
Alcohol Clin Exp Res. 2011 Aug;35(8):1529-33
pubmed: 21463342
J Neurosci. 2004 Nov 17;24(46):10542-52
pubmed: 15548669
J Neuropsychiatry Clin Neurosci. 2017 Spring;29(2):142-147
pubmed: 27852165
Alcohol Res Health. 1999;23(3):207-13
pubmed: 10890816
Drug Alcohol Depend. 2015 Sep 1;154:1-13
pubmed: 26072219
Eur J Neurosci. 2013 Feb;37(4):607-12
pubmed: 23189980
Alcohol Res. 2016;38(1):83-94
pubmed: 27159815
J Neurochem. 2009 Jun;109(5):1459-68
pubmed: 19453942
Transl Psychiatry. 2017 Apr 25;7(4):e1108
pubmed: 28440812
Hum Reprod. 2009 Sep;24(9):2303-9
pubmed: 19491202
Cell Mol Neurobiol. 2018 Apr;38(3):579-593
pubmed: 28623429
Psychopharmacology (Berl). 2018 Jun;235(6):1727-1743
pubmed: 29654346
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:193-8
pubmed: 23023098
Alcohol Clin Exp Res. 2011 Nov;35(11):1966-73
pubmed: 21848960
Pharmacol Rev. 2012 Apr;64(2):238-58
pubmed: 22407616
Cell Metab. 2019 Apr 2;29(4):917-931.e4
pubmed: 30661931
Transl Psychiatry. 2015 Dec 15;5:e696
pubmed: 26670281
Biol Psychiatry. 2005 May 1;57(9):1068-72
pubmed: 15860348
Mol Psychiatry. 2015 Aug;20(8):916-30
pubmed: 25824305
Trends Psychiatry Psychother. 2017 Jul-Sep;39(3):147-157
pubmed: 28813110
Cereb Cortex. 2017 Mar 1;27(3):2175-2182
pubmed: 27005989
Alcohol Clin Exp Res. 2004 Nov;28(11):1609-12
pubmed: 15547445
J Neurosci. 2012 Mar 21;32(12):4092-101
pubmed: 22442074
Psychopharmacology (Berl). 2005 Jun;180(1):95-9
pubmed: 15918078
Pharmacol Rep. 2010 Sep-Oct;62(5):938-41
pubmed: 21098877
Cell. 2003 Jan 24;112(2):257-69
pubmed: 12553913
Alcohol Clin Exp Res. 2017 Apr;41(4):836-845
pubmed: 28281290
Neuropsychopharmacology. 2016 Dec;41(13):3080-3091
pubmed: 27417517
J Anxiety Disord. 2015 Apr;31:108-13
pubmed: 25795078
Psychopharmacology (Berl). 2018 Apr;235(4):1191-1198
pubmed: 29392373
J Affect Disord. 2015 Mar 15;174:432-40
pubmed: 25553404
Neuropsychopharmacology. 2005 Jul;30(7):1353-61
pubmed: 15770238
Neurobiol Aging. 2005 Jan;26(1):115-23
pubmed: 15585351
Int J Geriatr Psychiatry. 2019 Nov;34(11):1706-1714
pubmed: 31368178

Auteurs

Jeanelle Portelli (J)

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Bethesda, MD, United States.

Mehdi Farokhnia (M)

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Bethesda, MD, United States; Center on Compulsive Behaviors, National Institutes of Health, Bethesda, MD, United States; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.

Sara L Deschaine (SL)

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Bethesda, MD, United States.

Jillian T Battista (JT)

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Bethesda, MD, United States.

Mary R Lee (MR)

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Bethesda, MD, United States.

Xiaobai Li (X)

Biostatistics and Clinical Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, MD, United States.

Dorit Ron (D)

Department of Neurology, University of California San Francisco, San Francisco, CA, United States.

Lorenzo Leggio (L)

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Bethesda, MD, United States; Center on Compulsive Behaviors, National Institutes of Health, Bethesda, MD, United States; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, United States; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI, United States. Electronic address: lorenzo.leggio@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH